Rapport Therapeutics, Inc. - Common Stock (NQ:RAPP)
34.49
+0.32
(+0.94%)
Streaming Delayed Price
Updated: 10:54 AM EDT, Apr 13, 2026
Add to My Watchlist
Price and Volume
Detailed Quote| Volume | 35,056 |
| Open | 34.18 |
| Bid (Size) | 34.41 (100) |
| Ask (Size) | 34.59 (200) |
| Prev. Close | 34.17 |
| Today's Range | 34.13 - 35.52 |
| 52wk Range | 7.730 - 42.27 |
| Shares Outstanding | N/A |
| Dividend Yield | N/A |
Top News
More News
Performance
More News
Read More
Rapport Therapeutics to Participate in Upcoming Investor Conferences
February 24, 2026
Rapport Therapeutics to Participate in Upcoming Investor Conferences
November 05, 2025
12 Health Care Stocks Moving In Wednesday's Intraday Session ↗
September 10, 2025
Rapport Announces Pricing of Public Offering of Common Stock
September 09, 2025
Let's take a look at the stocks that are in motion in today's session. ↗
September 09, 2025
Rapport Announces Proposed Public Offering of Common Stock
September 08, 2025
Frequently Asked Questions
Is Rapport Therapeutics, Inc. - Common Stock publicly traded?
Yes, Rapport Therapeutics, Inc. - Common Stock is publicly traded.
What exchange does Rapport Therapeutics, Inc. - Common Stock trade on?
Rapport Therapeutics, Inc. - Common Stock trades on the Nasdaq Stock Market
What is the ticker symbol for Rapport Therapeutics, Inc. - Common Stock?
The ticker symbol for Rapport Therapeutics, Inc. - Common Stock is RAPP on the Nasdaq Stock Market
What is the current price of Rapport Therapeutics, Inc. - Common Stock?
The current price of Rapport Therapeutics, Inc. - Common Stock is 34.49
When was Rapport Therapeutics, Inc. - Common Stock last traded?
The last trade of Rapport Therapeutics, Inc. - Common Stock was at 04/13/26 10:54 AM ET
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.
Facebook
Twitter
YouTube